Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation
- PMID: 19375057
- PMCID: PMC2680999
- DOI: 10.1016/j.ajhg.2009.03.019
Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation
Abstract
Familial progressive hyperpigmentation (FPH) is an autosomal-dominantly inherited disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age. The genetic basis for FPH remains unknown. In this study, a six-generation Chinese family with FPH was subjected to a genome-wide scan for linkage analysis. Two-point linkage analysis mapped the locus for FPH at chromosome 12q21.31-q23.1, with a maximum two-point LOD score of 4.35 (Ø = 0.00) at D12S81. Haplotype analysis confined the locus within an interval of 9.09 cM, flanked by the markers D12S1667 and D12S2081. Mutation profiling of positional candidate genes detected a heterozygous transversion (c. 107A-->G) in exon 2 of the KIT ligand (KITLG) gene, predicted to result in the substitution of a serine residue for an asparagine residue at codon 36 (p.N-->S). This mutant "G" allele cosegregated perfectly with affected, but not with unaffected, members of the FPH family. Function analysis of the soluble form of sKITLG revealed that mutant sKITLGN36S increased the content of the melanin by 109% compared with the wild-type sKITLG in human A375 melanoma cells. Consistent with this result, the tyrosinase activity was significantly increased by mutant sKITLGN36S compared to wild-type control. To our knowledge, these data provided the first genetic evidence that the FPH disease is caused by the KITLGN36S mutation, which has a gain-of-function effect on the melanin synthesis and opens a new avenue for exploration of the genetic mechanism of FPH.
Figures


Similar articles
-
Linkage of a locus determining familial progressive hyperpigmentation (FPH) to chromosome 19p13.1-pter in a Chinese family.Eur J Dermatol. 2006 May-Jun;16(3):246-50. Eur J Dermatol. 2006. PMID: 16709486
-
KITLG mutations cause familial progressive hyper- and hypopigmentation.J Invest Dermatol. 2011 Jun;131(6):1234-9. doi: 10.1038/jid.2011.29. Epub 2011 Mar 3. J Invest Dermatol. 2011. PMID: 21368769
-
[Progressive familial hyperpigmentation is associated with mutations activating the KIT receptor ligand].Ann Dermatol Venereol. 2010 Mar;137(3):247. doi: 10.1016/j.annder.2009.11.002. Epub 2009 Dec 16. Ann Dermatol Venereol. 2010. PMID: 20227574 French. No abstract available.
-
The biology of hyperpigmentation syndromes.Pigment Cell Melanoma Res. 2014 Jul;27(4):512-24. doi: 10.1111/pcmr.12235. Epub 2014 Mar 20. Pigment Cell Melanoma Res. 2014. PMID: 24612852 Review.
-
Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.Fam Cancer. 2018 Apr;17(2):247-253. doi: 10.1007/s10689-017-0024-8. Fam Cancer. 2018. PMID: 28710566 Review.
Cited by
-
Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.PLoS One. 2010 Dec 10;5(12):e15170. doi: 10.1371/journal.pone.0015170. PLoS One. 2010. PMID: 21170325 Free PMC article.
-
[Hereditary pigmentary disorders].Hautarzt. 2010 Jul;61(7):567-77. doi: 10.1007/s00105-009-1917-8. Hautarzt. 2010. PMID: 20556350 German.
-
Prediction of Skin Color Using Forensic DNA Phenotyping in Asian Populations: A Focus on Thailand.Biomolecules. 2025 Apr 9;15(4):548. doi: 10.3390/biom15040548. Biomolecules. 2025. PMID: 40305359 Free PMC article. Review.
-
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.Nat Genet. 2022 May;54(5):637-648. doi: 10.1038/s41588-022-01059-2. Epub 2022 May 5. Nat Genet. 2022. PMID: 35513723 Free PMC article.
-
Familial testicular germ cell tumours.Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):503-13. doi: 10.1016/j.beem.2010.01.005. Best Pract Res Clin Endocrinol Metab. 2010. PMID: 20833340 Free PMC article. Review.
References
-
- Chernosky M.E., Anderson D.E., Chang J.P., Shaw M.W., Romsdahl M.M. Familial progressive hyperpigmentation. Arch. Dermatol. 1971;103:581–598. - PubMed
-
- Rebora A., Parodi A. Universal inherited melanodyschromatosis: A case of melanosis universalis hereditaria? Arch. Dermatol. 1989;125:1442–1443. - PubMed
-
- Ling D.B., Lo T. Familial progressive hyperpigmentation: A family study in China. Br. J. Dermatol. 1991;125:607. - PubMed
-
- Zhang C., Deng Y., Chen X., Wu X., Jin W., Li H., Yu C., Xiong Y., Zhou L., Chen Y. Linkage of a locus determining familial progressive hyperpigmentation (FPH) to chromosome 19p13.1-pter in a Chinese family. Eur. J. Dermatol. 2006;16:246–250. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous